Yulong Eco-Materials Limited (NASDAQ:YECO) tinted gains of +3.25% (+0.08 points) to US$2.54. The volume of 0.26 Million shares climbed down over an trading activity of 105.32 Million shares. EPS ratio determined by looking at last 12 month figures is -3.08. Over the same time span, the stock marked US$9 as its best level and the lowest price reached was US$0.03. The corporation has a market cap of US$6.09 Million.
Yulong Eco-Materials Limited (NASDAQ:YECO)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 0.84 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
American Renal Associates Holdings, Inc. (NYSE:ARA) is worth US$501.65 Million and has recently risen 3.19% to US$15.83. The latest exchange of 0.31 Million shares is below its average trading activity of 156.52 Million shares. The day began at US$15.11 but the price moved to US$15.11 at one point during the trading and finally capitulating to a session high of US$15.91. The stock tapped a 52-week high of US$24.07 while the mean 12-month price target for the shares is US$23.
Currently, the stock carries a price to earnings ratio of 202.95, a price to book ratio of 0, and a price to sales ratio of 0.66. For the past 5 years, the company’s revenue has grown 12.1%, while the company’s earnings per share has grown -24.2%. With an institutional ownership near 91%, it carries an earnings per share ratio of 0.08.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.